Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?The Motley Fool • 10/01/26
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer's Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer's DayGlobeNewsWire • 09/21/26
5 Stocks In The Spotlight Last Week: Wall Street's Most Accurate Analysts Weigh InBenzinga • 09/21/26
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer's Launch Gains TractionMarketBeat • 09/19/26
Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright ConferenceMarketBeat • 09/19/26
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?The Motley Fool • 09/18/26
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/18/26
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/18/26
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026GlobeNewsWire • 09/17/26
Axsome Therapeutics, Inc. (AXSM) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks TranscriptSeeking Alpha • 09/16/26
Axsome Therapeutics, Inc. (AXSM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/11/26
Axsome Therapeutics, Inc. (AXSM) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/10/26
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/10/26
Axsome Therapeutics, Inc. (AXSM) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/09/26
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking CessationGlobeNewsWire • 08/31/26
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 08/29/26
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to RunThe Motley Fool • 08/23/26
Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y RevenuesZacks Investment Research • 08/11/26
Axsome Therapeutics Q2 Earnings Review: I Just Can't See The Value PropositionSeeking Alpha • 08/11/26